Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

B cell-deficient mice display markedly enhanced resistance to the intracellular bacterium Brucella abortus.

Goenka R, Parent MA, Elzer PH, Baldwin CL.

J Infect Dis. 2011 Apr 15;203(8):1136-46. doi: 10.1093/infdis/jiq171.

3.

Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.

Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.

Infect Immun. 2009 Jan;77(1):436-45. doi: 10.1128/IAI.01151-08. Epub 2008 Nov 3. Erratum in: Infect Immun. 2009 Apr;77(4):1719.. Samartino, Clara García [corrected to García Samartino, Clara].

4.
7.

Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308.

Fernandes DM, Jiang X, Jung JH, Baldwin CL.

FEMS Immunol Med Microbiol. 1996 Dec 31;16(3-4):193-203.

PMID:
9116636
8.

Antigen-specific activation and proliferation of CD4+ and CD8+ T lymphocytes from brucellosis patients.

Moreno-Lafont MC, López-Santiago R, Zumarán-Cuéllar E, Paredes-Cervantes V, López-Merino A, Estrada-Aguilera A, Santos-Argumedo L.

Trans R Soc Trop Med Hyg. 2002 May-Jun;96(3):340-7.

PMID:
12174793
10.

Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.

Araya LN, Elzer PH, Rowe GE, Enright FM, Winter AJ.

J Immunol. 1989 Nov 15;143(10):3330-7.

PMID:
2509555
11.

An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response.

Hu XD, Chen ST, Li JY, Yu DH, Yi-Zhang, Cai H.

Vaccine. 2010 Mar 11;28(12):2408-15. doi: 10.1016/j.vaccine.2009.12.076. Epub 2010 Jan 9.

PMID:
20064480
12.
13.

Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.

Mallick AI, Singha H, Chaudhuri P, Nadeem A, Khan SA, Dar KA, Owais M.

Vaccine. 2007 May 4;25(18):3692-704. Epub 2007 Jan 25.

PMID:
17296251
14.

Immune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51.

Stevens MG, Olsen SC, Palmer MV, Pugh GW Jr.

Infect Immun. 1996 Nov;64(11):4534-41.

15.

Relative importance of CD4+ and CD8+ T cells in the resolution of Chlamydophila abortus primary infection in mice.

Martínez CM, Buendía AJ, Sánchez J, Ortega N, Caro MR, Gallego MC, Navarro JA, Cuello F, Salinas J.

J Comp Pathol. 2006 May;134(4):297-307. Epub 2006 May 19.

PMID:
16712864
16.

Central role of MyD88-dependent dendritic cell maturation and proinflammatory cytokine production to control Brucella abortus infection.

Macedo GC, Magnani DM, Carvalho NB, Bruna-Romero O, Gazzinelli RT, Oliveira SC.

J Immunol. 2008 Jan 15;180(2):1080-7.

17.

Immune control of Brucella abortus 2308 infections in BALB/c mice.

Murphy EA, Parent M, Sathiyaseelan J, Jiang X, Baldwin CL.

FEMS Immunol Med Microbiol. 2001 Dec;32(1):85-8.

18.

Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice.

Murphy EA, Sathiyaseelan J, Parent MA, Zou B, Baldwin CL.

Immunology. 2001 Aug;103(4):511-8.

19.
20.

Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus.

Singha H, Mallick AI, Jana C, Isore DP, Goswami TK, Srivastava SK, Azevedo VA, Chaudhuri P, Owais M.

Microbes Infect. 2008 Aug-Sep;10(10-11):1089-96. doi: 10.1016/j.micinf.2008.05.007. Epub 2008 Jun 17.

PMID:
18602490
Items per page

Supplemental Content

Write to the Help Desk